The Ohio State Board of Pharmacy is taking steps to reverse a rule that limits state residents from transferring a prescription from one pharmacy to another more than once per year.
The rule, which took effect Jan. 1, was popular among pharmacists but criticized by consumers, who labeled it anti-competitive, the Columbus Dispatch reported.
The Board of Pharmacy has filed paperwork with the Register of Ohio that would overturn the rule, which curiously was essentially dictated to state residents by the Board of Pharmacy; legislators and voters had little say in the matter.
The Register of Ohio is to hold a hearing in May to discuss changing the rule back to its original form. The change should be in effect by June, said William Winsley, executive director of the Board of Pharmacy.
Advocates of the one-transfer rule said it was about patient safety. Transferring prescriptions multiple times can lead to miscommunication amongst pharmacists that could bring errors that hurt patients, they said.
But that claim may have been a dubious one because the Board of Pharmacy has no data on errors caused by prescription transfers, just anecdotal evidence from pharmacists. That would seem to only fuel consumers’ suspicions that the one-transfer rule was really about pharmacies protecting themselves from competition.
Perhaps the most controversial aspect of the one-transfer rule pitted big retail drug chains like Walgreens and CVS against small, independent pharmacists. That is, the rule carved out an exception for transfers between locations as long as the prescription records were housed within the same computer system.
So for example, a patient would have been able to transfer her prescription from the Walgreens near her home to the one by her office, and again to the location by her child’s school to any number of other Walgreens locations that she prefers. With a small, independent retailer, the patient could transfer once a year and that’s it.
But now fears of hardships the one-transfer rule would impose on Ohio prescription drug buyers appear to be melting away, and, as of June, consumers look likely to be able to once again change prescription locations at will.

Comments
Post a comment
This is another misunderstanding of the rule printed by the media. Please research the facts before you issue something others will read and take as Gospel because it is in the media. First, this was the Board taking a stand on transfer coupons without actually issuing an opinion on them. They are outlawed in NY and NJ and they don’t complain about anti-competitve rules. Second, patients do not need to transfer a prescription multiple times. If they are on insurance, their copay will be the same. If they are cash-paying customers, they can call for the lowest price, then go there. The prices will not change from month-to-month. Third, the one transfer per prescription rule is just that “once per prescription”. It is not a “one transfer per year” rule as every major media outlet has reported. A patient can easily go to his doctor, have him write 2 prescriptions for the same drug, fill one in Ohio and take the other to Florida, no problem. Fourth, independent pharmacies are not at risk. The rule about a shared computer system benefits someone like the snow birds because there is a chain store in both states. Prior to this rule, controlled medications were the only ones that could be transferred once, unless it was within a shared system. Independents didn’t complain about this. In fact, of the independent retailers I spoke with since this rule took effect, not one has complained about the demise of their practices. Fifth, anecdotal evidence is all we have regarding errors with transfers because they are very difficult to track. In my 15 years as a pharmacist, I have found incorrect drugs being filled, duplications in therapy from multiple pharmacies and doctors, wrong strengths, wrong quantities, etc. I wish all of the media would actually take the time to represent the Board’s purpose and rules accurately. As I stated in my letter to the Board, if they are changing rules due to customer complaints instead of safety concerns (business?), they are interested now only in the Economics of Pharmacy instead of the Practice of Pharmacy.
Comment by Jason — April 19, 2011 @ 10:04 am
Post a Comment